Ritgovi Tablets 4mg

Ritgovi Tablets 4mg, from Taiho Pharmaceutical, contains Futibatinib (YJ code: 4291080F1029, standard: 4mg 1 tablet). This medication is a selective and irreversible inhibitor of fibroblast growth factor receptor (FGFR) 1, 2, 3, and 4. It is used for the treatment of previously treated, unresectable, locally advanced or metastatic intrahepatic cholangiocarcinoma harboring FGFR2 gene fusions or other rearrangements.